Arthur F. Ryan

Insider Reports History

Entity
Individual
Location
Citizens Financial Group, Inc, 600 Washington Boulevard, Stamford, Connecticut
Signature
/s/**Arthur F. Ryan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur F. Ryan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 17,882 $19.1 M $1,068.09 Jul 1, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1,607 Jan 2, 2024 Direct

Insider Reports Filed by Arthur F. Ryan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Jul 1, 2024 19 -105,924 4 Jul 2, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 3, 2024 16 -99,450 4 Jun 5, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. May 1, 2024 23 -89,961 4 May 3, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 1, 2024 9 -96,253 4 Apr 3, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 1, 2024 21 -98,205 4 Mar 5, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 1, 2024 21 -95,422 4 Feb 5, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 15 -89,990 4 Jan 4, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 1, 2023 19 -81,730 4 Dec 4, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Nov 7, 2023 8 -82,790 4 Nov 8, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 1, 2023 11 -73,659 4 Aug 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jul 3, 2023 10 -71,688 4 Jul 6, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 1, 2023 9 -73,542 4 Jun 2, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. May 1, 2023 7 -80,533 4 May 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 3, 2023 8 -81,931 4 Apr 5, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 1, 2023 9 -76,250 4 Mar 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 1, 2023 11 -75,613 4 Feb 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 14 -72,629 4 Jan 5, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 1, 2022 15 -75,817 4 Dec 2, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Nov 1, 2022 10 -75,589 4 Nov 3, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 14 -72,654 4 Oct 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 6, 2022 12 -58,237 4 Sep 8, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 4, 2022 10 -2,174,484 4 Aug 8, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. May 2, 2022 15 -65,078 4 May 3, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 1, 2022 14 -69,281 4 Apr 4, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 1, 2022 17 -61,837 4 Mar 3, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 1, 2022 12 -60,714 4 Feb 2, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2022 10 -62,495 4 Jan 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 1, 2021 12 -63,753 4 Dec 2, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Nov 1, 2021 10 -64,252 4 Nov 3, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 1, 2021 17 -56,949 4 Oct 4, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 1, 2021 13 -67,628 4 Sep 3, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 2, 2021 9 -57,795 4 Aug 4, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Jul 1, 2021 13 -56,450 4 Jul 2, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 14, 2021 7 -52,476 4 Jun 16, 2021 Director